Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Restoring Insulin Secretion Adult Medication Study

Trial Profile

Restoring Insulin Secretion Adult Medication Study

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 09 Jun 2019

At a glance

  • Drugs Insulin glargine (Primary) ; Liraglutide (Primary) ; Metformin (Primary)
  • Indications Prediabetic state; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms RISE Adult
  • Most Recent Events

    • 09 Jun 2019 According to a American Diabetes Association media release, data from this study recently publised in ADA's flagship journal Diabetes Care
    • 09 Jun 2019 According to a American Diabetes Association media release, data from this study were presented at the American Diabetes Association's (ADA's) 79th Scientific Sessions.
    • 29 Aug 2018 Planned End Date changed from 1 Mar 2019 to 1 Aug 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top